Related Experiment Video
Updated: Jun 13, 2026

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Muralikrishna Gopal1, Archana Bhaskaran, Wissam I Khalife
1Department of Internal Medicine, University of Texas Medical Branch (UTMB), 301, University Boulevard, Galveston, TX-77550, USA.
Insights
HIV/AIDS is a growing global health issue. Managing cardiac complications in HIV/AIDS patients requires understanding opportunistic infections and HAART effects on heart health.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- Human immunodeficiency virus/Acquired immuno deficiency syndrome (HIV/AIDS) is a significant global health concern.
- Highly active antiretroviral therapy (HAART) has increased patient longevity, transforming HIV/AIDS into a chronic disease burden.
- Cardiac manifestations in HIV/AIDS patients present diagnostic and therapeutic challenges for cardiologists.
Purpose of the Study:
- To outline an approach for diagnosing cardiac disease in HIV/AIDS patients.
- To highlight the importance of understanding cardiac opportunistic infections and HAART effects.
- To emphasize the need for tailored treatment strategies for cardiac conditions in this population.
Main Methods:
- Algorithmic and anatomic diagnostic approach.
- Review of cardiac manifestations related to opportunistic infections.
- Analysis of the impact of HAART, including protease inhibitors, on cardiovascular health.
- Consideration of drug interactions and treatment responsiveness in HIV/AIDS patients.
Main Results:
- Cardiac disease localization to endocardium, myocardium, and pericardium is achievable.
- HAART, particularly protease inhibitors, can affect lipid and glucose metabolism, potentially accelerating vascular disease.
- Specific knowledge of cardiac opportunistic infections and HAART's cardiac effects is crucial for differential diagnosis.
Conclusions:
- An algorithmic, anatomic approach aids in diagnosing cardiac disease in HIV/AIDS.
- Understanding the interplay between HIV/AIDS, HAART, and cardiac health is essential for effective management.
- Further research is needed to optimize cardiac disease treatment in HIV/AIDS patients due to unique factors like drug interactions.
Abstract:
HIV/AIDS (Human immunodeficiency virus/ Acquired immuno deficiency syndrome) is a growing global problem, in terms of its incidence and mortality. Patients with HIV/AIDS are living much longer with HAART (Highly active antiretroviral therapy) therapy so much so that HIV/AIDS has now become a part of the chronic disease burden, like hypertension and diabetes. Patients with HIV/AIDS and symptoms suggestive of cardiac disease represent a diagnostic and therapeutic challenge in clinical practice; Cardiologists are more frequently encountering this problem. An algorithmic, anatomic approach to diagnosis, localizing disease to the endocardium, myocardium and pericardium can be useful. An intimate knowledge of opportunistic infections affecting the heart, effects of HAART therapy and therapy for opportunistic infections on the heart is needed to be able to formulate a differential diagnosis. Effects of HAART therapy, especially protease inhibitors on lipid and glucose metabolism, and their influence on progression to premature vascular disease require consideration. Treatment of cardiac disease, in HIV/AIDS patients can vary from non-HIV patients, based on drug interactions, differences in responsiveness, and other factors; and this area requires further research.
More Related Videos
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Heart Failure III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Sexually Transmitted Infections
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...